Tag: Ivascular
Luminor DCB now reimbursed in France
Luminor 18 and Luminor 35 drug-coated balloons (DCB; iVascular) are now listed on the French LPPR list for de novo lesions of the femoropopliteal...
TINTIN trial shows “impressive” results at six months
The six-month results of TINTIN (Treatment with the lumINor DCB and The IVolutioN self-expanding stent) trial have been revealed at the annual meeting of the Cardiovascular and...
Experts discuss latest results from EFFPAC and TINTIN trials presented at...
NOTE: ONLY intended for healthcare professionals outside of the USA.
Ulf Teichgräber (Jena, Germany) and Koen Deloose (Dendermonde, Belgium) discuss the 24-month results of the...
BIBLIOS trial has obtained ethics approval and initiated patient enrolment
The BIBLIOS trial has received Ethics Committee (EC) approval, and enrolled its first patient. This announcement comes from Wouter Lansink, who will be treating this...
Enrolment complete in T.I.N.T.I.N. study
iVascular has announced the completion of enrolment of patients in its T.I.N.T.I.N. (Treatment with the Luminor DCB and the iVolution self-expanding stent) study.
The effectiveness...
CX 2018: Ulf Teichgräber discusses EffPAC trial 12-month results
Ulf Teichgräber, Jena, Germany, discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018
Luminor DCB shows high clinical effectiveness in six-month EffPAC data
The six-month results from the full clinical cohort of the EffPAC randomised study were presented in the drug-coated balloon (DCB) abstracts session at the...
Ivolution now available in 200mm length devices
Ivascular has announced the product range extension of its self-expandable stent, iVolution, to 200mm length, in various diameters.
Ivolution is a nitinol endovascular stent, combining...